Enlitic Inc · ASX:ENL
Enlitic — Shareholder Meeting (May 2024)
24 slides from Enlitic's shareholder meeting presentation, May 16, 2024
Slide 1: ASX Announcement: AGM Presentation and Addresses
ASX Announcement 16 May 2024 Annual General Meeting – Presentation and Addresses Enlitic, Inc. (ASX: ENL) (“the Company”) attaches a copy of the Chair address and presentation to be made at today’s Annual General Meeting of the Company. – ENDS – For personal use only This announcement was authorised
Slide 2: Chairman's Address
ASX Announcement 16 May 2024 Enlitic, Inc. 2023 Annual General Meeting Chairman’s Address Dear Shareholders, For personal use only It’s my pleasure to welcome all our shareholders to Enlitic’s Annual General Meeting 2023. I'd like to take this opportunity today to discuss four key areas as part of m
Slide 3: Chairman's Address (continued)
ASX Announcement Commercially, we saw robust growth. We signed ten new contracts with partners across a diverse spectrum of healthcare providers and OEM healthcare vendors, including notable entities like Sentara Health, Summit Health, Wake Radiology, and Blackford Analysis. These new alliances shou
Slide 4: Enquiries and About Enlitic
ASX Announcement This announcement was authorised for release by the Board of Enlitic, Inc. For personal use only Enquiries Enlitic Investor Relations Australia: USA: invest_au@enlitic.com invest@enlitic.com About Enlitic At Enlitic, we empower healthcare systems to enhance the quality of their medi
Slide 5: AI Driven Data Management for the Medical Imaging Sector
For personal use only ENLITIC, INC. AI DRIVEN DATA MANAGEMENT FOR THE MEDICAL IMAGING SECTOR Annual General Meeting 16 May 2024
Slide 6: Important Notice and Disclaimer
Important Notice and Disclaimer This presentation has been prepared by Enlitic, Inc. (Enlitic or the Company) to provide summary information about the Company and its associated entities as at the date of this presentation, and the information in this presentation remains subject to change without n
Slide 7: Board and Executive Management
BOARD AND EXECUTIVE OUR MISSION MANAGEMENT Board of Directors Executive Management For personal use only Lawrence B. Gozlan Michael Sistenich Board Chair Director & Chief Executive Officer Mr. Gozlan is the Chief Investment Officer and Founder of Scientia Michael has over 24 years of experience in t
Slide 8: Agenda
AGENDA OUR MISSION For personal use only Welcome & Chairman’s Address Formal Items of Business Resolutions & Questions Closure of Annual General Meeting CEO’s Presentation Milestones in 2023 Pipeline Growth Pathway & Outlook Q&A
Slide 9: Chairman's Address
CHAIRMAN’S OUR MISSION For personal use only ADDRESS Lawrence Gozlan, Chairman
Slide 10: Our Mission
OUR MISSION OUR MISSION Our Mission For personal use only Enlitic’s mission is to revolutionise healthcare by leveraging AI and data, empowering evidence-based decision-making, enhancing research, and transforming healthcare delivery. Industry Problems Solution Radiology departments are experiencing
Slide 11: 2023 in Review
2023 IN REVIEW OUR MISSION For personal use only STRATEGIC PIVOT TO FURTHER PRODUCT AUD $21M DEVELOPMENT AND STRENGTHENED SUBSCRIPTION- INITIAL PUBLIC BASED REVENUE COMMERCIALISATION LEADERSHIP OF ENDEX & ENCOG OFFERING MODEL USD $9.5M LISTING ON THE 10 NEW CLIENT AUSTRALIAN CONTRACTS REDUCTION SECU
Slide 12: CEO Presentation
CEO PRESENTATION OUR MISSION For personal use only Michael Sistenich, CEO
Slide 13: What We Do
WHAT WE DO OUR MISSION For personal use only We improve workflows and efficiencies: Radiologists report faster, with less manual Enlitic empowers healthcare intervention systems to enhance the quality of PACS Admin spend less time searching and their medical imaging data using the rerouting data cap
Slide 14: 2023 Highlights
2023 HIGHLIGHTS OUR MISSION For personal use only 10 successful contractual arrangements January March April May • Marubeni Japanese • Sentara Health • Multi, Inc. distribution • Clairvo distribution agreement contractual agreement agreement Technologies/JMID • Release of Enlitic Curie • Vital Radio
Slide 15: 2024 Achievements
2024 ACHIEVEMENTS OUR MISSION For personal use only February March April March-May Strengthened the Unilabs contractual OpenRad contractual Multiple Proof of Executive team and agreement expanded agreement signed Concepts underway with organization beyond TMC increased client interest May May May Ma
Slide 16: Our Software
OUR SOFTWARE OURIMPACT HAS MISSION Healthcare has always been challenged to transform the massive amounts of For personal use only data it produces into actionable insights. 90% of the healthcare data produced >50% Of healthcare executives consider 97% of this data remains unutilized comes from imag
Slide 17: Key Customers
KEY KEY CUSTOMERS CUSTOMERS HEALTHCARE PROVIDERS PARTNERSHIPS & RESELLERS For personal use only NEW in 2024 NEW in 2024 NEW in 2024 NEW in 2024
Slide 18: Ensight 2.0
ENSIGHT 2.0 OUR MISSION For personal use only Data model Improved metrics improvements & dashboards for with increased performance capabilities, monitoring and EXPECTED RELEASE improved data quality accuracy analysis 3 4 MID-2024 Ensight 2.0 Configurable Fully integrated KEY COMPONENTS AND framework
Slide 19: Working Toward Our Goals
WORKING TOWARD OURGOALS OUR MISSION Enlitic is approaching an inflection point For personal use only CURRENT WORKFLOW ENSIGHT 2.0 “THE PRIZE” Current Workflow Processes: Key components and infrastructure of the new: Data Common Data Model (CDM) Referring Clinics Primary Hospital Referring Hospital 1
Slide 20: 2024 Opportunities & Key Initiatives
2024 OPPORTUNITIES & OUR KEY MISSION INITIATIVES PRODUCT • Expanding workflows and use cases For personal use only ENRICHMENT • Improve integration capabilities SALES • Reduce time to revenue CONVERSION • Enable partners and resellers to be successful MARKET • Drive awareness of the value of our sol
Slide 21: Growth Pathways & Strategies
GROWTH PATHWAYS &OUR MISSION STRATEGIES For personal use only Five key areas of growth for Enlitic: CURRENT INCREASED M&A NEW CUSTOMERS NEW SOLUTIONS REVENUE SHARING BUSINESS VOLUMES OPPORTUNITIES Pipeline of Increasing ENCODE Coding and Revenue sharing data Monitor potential opportunities
Slide 22: Pipeline Summary
PIPELINE OUR MISSION Pipeline Summary1 For personal use only Enlitic tracks progress of prospective clients across all phases of the sales cycle Pipeline Stage # TCV Pipeline Stage # TCV LEADS 2,027 PENDING $37.7M PROGRESSION2 43 USD WORKING LEAD 1,382 OPEN $62.4M OPPORTUNITY3 84 USD MARKETING QUALI
Slide 23: Summary
SUMMARY OUR MISSION For personal use only Initial feedback from testing of ENSIGHT 2.0 has been strong, driving further inbound customer interest and is expected to reduce sales cycles. Accelerated R&D has enabled Enlitic to bring vital infrastructure components of ENSIGHT and ENCODE forward by 18 m
Slide 24: Questions?
For personal use only Questions?